文献

J-GLOBAL ID：201702272706321730   整理番号：17A1188555

ネフロン温存手術を施行した限局性嫌色素性癌は優れた腫瘍学的転帰を有する【Powered by NICT】

Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes

著者 (80件)： Bigot Pierre (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Bigot Pierre (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Bigot Pierre (Department of Urology, Angers University Hospital, Angers, France) ,  Bigot Pierre (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Bernhard Jean-Christophe (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Bernhard Jean-Christophe (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Bernhard Jean-Christophe (Department of Urology, Bordeaux University Hospital, Bordeaux, France) ,  Bernhard Jean-Christophe (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Flamand Vincent (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Flamand Vincent (Department of Urology, Lille University Hospital, Lille, France) ,  Flamand Vincent (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Gill Inderbir (USC Institute of Urology, University of Southern California, Los Angeles, CA) ,  Gill Inderbir (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Verhoest Gregory (Department of Urology, Pontchaillou University Hospital, Rennes, France) ,  Verhoest Gregory (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Verhoest Gregory (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Beauval Jean Baptiste (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Beauval Jean Baptiste (Department of Urology, Toulouse University Hospital, Toulouse, France) ,  Beauval Jean Baptiste (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Nouhaud Francois Xavier (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Nouhaud Francois Xavier (Department of Urology, Rouen University Hospital, Rouen, France) ,  Nouhaud Francois Xavier (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Suer Evren (Department of Urology, University Hospital of Ankara, Ankara, Turkey) ,  Suer Evren (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Ploussard Guillaume (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Ploussard Guillaume (Department of Urology, Saint-Louis University Hospital, APHP, Paris, France) ,  Ploussard Guillaume (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Hetet Jean Francois (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Hetet Jean Francois (Department of Urology, Clinique Jules Vernes, Nantes, France) ,  Hetet Jean Francois (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Rigaud Jerome (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Rigaud Jerome (Department of Urology, Nantes University Hospital, Nantes, France) ,  Rigaud Jerome (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Baco Eduard (Department of Urology, University Hospital of Oslo, Oslo, Norway) ,  Baco Eduard (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Larre Stephane (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Larre Stephane (Department of Urology, Reims University Hospital, Reims, France) ,  Larre Stephane (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Sebe Philippe (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Sebe Philippe (Department of Urology, Groupe hospitalier Diaconesses, Paris, France) ,  Sebe Philippe (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Koutlidis Nicolas (Department of Urology, Dijon University Hospital, Dijon, France) ,  Koutlidis Nicolas (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Descazeaud Aurelien (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Descazeaud Aurelien (Department of Urology, Limoges University Hospital, Limoges, France) ,  Descazeaud Aurelien (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Eto Masatoshi (Department of Urology, University Hospital of Kumamoto, Kumamoto, Japan) ,  Eto Masatoshi (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Doerfler Arnaud (Department of Urology, Caen University Hospital, Caen, France) ,  Doerfler Arnaud (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Roupret Morgan (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Roupret Morgan (Department of Urology, La Pitie Salpetriere, APHP, Paris, France) ,  Roupret Morgan (Faculty of Medicine Pierre and Marie Curie, University Paris 6, Paris, France) ,  Roupret Morgan (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Vuong Nam Son (Department of Urology, Bordeaux University Hospital, Bordeaux, France) ,  Vuong Nam Son (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Reix Boris (Department of Urology, Lille University Hospital, Lille, France) ,  Reix Boris (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Matsugasumi Toru (USC Institute of Urology, University of Southern California, Los Angeles, CA) ,  Matsugasumi Toru (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Bakri Adnan El (Department of Urology, Groupe hospitalier Diaconesses, Paris, France) ,  Bakri Adnan El (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Albiges Laurence (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Albiges Laurence (Medical Oncology Department, University Paris 11, Villejuif, France) ,  Albiges Laurence (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Soulie Michel (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Soulie Michel (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Soulie Michel (Department of Urology, Toulouse University Hospital, Toulouse, France) ,  Soulie Michel (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Patard Jean-Jacques (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Patard Jean-Jacques (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Patard Jean-Jacques (Medical Oncology Department, University Paris 11, Villejuif, France) ,  Patard Jean-Jacques (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Mejean Arnaud (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Mejean Arnaud (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Mejean Arnaud (Department of Urology, HEGP, APHP, Paris, France) ,  Mejean Arnaud (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France) ,  Bensalah Karim (Cancerology Committee of the French Association of Urology (CCAFU), Paris, France) ,  Bensalah Karim (French Network for Research on Kidney Cancer (UroCCR), Bordeaux, France) ,  Bensalah Karim (Department of Urology, Bicetre University Hospital, Le Kremlin Bicetre, France)
資料名： Urologic Oncology: Seminars and Original Investigations  (Urologic Oncology: Seminars and Original Investigations)
巻： 35  号： 1  ページ： 35.e15-35.e19  発行年： 2017年 
JST資料番号： W3220A  ISSN： 1078-1439  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 局在嫌色素性腎細胞癌(cRCC)のためのネフロン温存手術(NSS)の腫瘍学的転帰を評価すること。腎癌(UroCCR)と5国際チームに関する研究のためのフランスのネットワークを含む多施設国際研究を行った。非淡明細胞型腎細胞癌のための2004と2014間のNSSで治療した808人の患者のデータを解析した。cRCCの234名の患者を含んでいた。123(52.6%)女性であった。年齢中央値は61(23 88)歳であった。腫瘍サイズの中央値は3(1 11)cmであった。切除断端陽性は14試料(6%)で同定された。病理段階は202(86.3%),9(3.8%),および23(9.8%)症例におけるT1,T2,およびT3aであった。46.6±36か月の平均追跡後,2(0.8%)の患者は局所再発を経験した。患者は転移性進行を示さなかった,癌で死亡した患者はいなかった。三年推定担癌生存および癌特異的生存率は99.1%と100%であった。局在cRCCのNSSの腫瘍学的結果は優れていた。本連載では,2人の患者のみが局所再発を呈したが,患者は転移性進行を示さなかったまたは癌のため死亡した。Copyright 2017 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【Powered by NICT】

シソーラス用語： 患者 ,  *ネフロン ,  生存率 ,  女性 ,  病理 ,  中央値 ,  *色素 ,  腎細胞癌
準シソーラス用語： 転移性 ,  局所再発 ,  腫瘍サイズ ,  嫌色素性腎細胞癌 ,  *転帰 ,  *腫瘍内科学 ,  *温存手術 , 【Automatic Indexing@JST】

著者キーワード (3件)： ネフロン-予備手術 ,  嫌色素性腎癌 ,  腫瘍学的転帰

分類 (2件)： 腫ようの外科療法  (GE03033T) ,  泌尿生殖器の腫よう  (GM04000S)

タイトルに関連する用語 (5件)： ネフロン ,  温存手術 ,  癌 ,  腫瘍学 ,  転帰